[Diuretic and renoprotective effects of natriuretic peptides].
Mukoyama
Masashi
M
Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine.
Suganami
Takayoshi
T
Nakao
Kazuwa
K
D000818:Animals; D017869:Cyclic GMP-Dependent Protein Kinases / Q000502:physiology; D004195:Disease Models, Animal; D004231:Diuresis / Q000187:drug effects*; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006162:Guanylate Cyclase / Q000502:physiology; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D007687:Kidney Tubules, Proximal / Q000378:metabolism; D009318:Natriuresis / Q000187:drug effects; D045265:Natriuretic Peptides / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D017461:Receptors, Atrial Natriuretic Factor / Q000502:physiology; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D018000:Receptors, Peptide / Q000502:physiology; D000099242:Atrial Natriuretic Factor Receptor B
D017869:Cyclic GMP-Dependent Protein Kinases; D006162:Guanylate Cyclase; D045265:Natriuretic Peptides; D017461:Receptors, Atrial Natriuretic Factor; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D018000:Receptors, Peptide; D000099242:Atrial Natriuretic Factor Receptor B; C091715:atrial natriuretic factor receptor A